MedTrace Logo

Is Robot-Assisted Therapy Effective for the Upper Extremity Following a Stroke

NCT05559385 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2022-10-03

No results posted yet for this study

Summary

The aim of this study was to investigate the effects on upper-limb motor function of the addition of robotic rehabilitation (RR) and conventional rehabilitation (CR) treatments to intensive trunk rehabilitation (ITR).

A total of 41 subacute stroke patients were randomly allocated to two groups: RR and CR. Both groups received the same ITR procedure (6x5x60 weeks/days/minutes). Following ITR, a robot-assisted rehabilitation program of 60 minutes, five days a week, for six weeks, was applied to the RR group, and an individualized upper extremity rehabilitation program to the CR group. Evaluations were made at baseline and after six weeks using the Trunk Impairment Scale (TIS), Fugl-Meyer Upper Extremity Motor Evaluation Scale (FMA-UE), and Wolf Motor Function Test (WMFT).

Conditions

Interventions

DEVICE

Robot-Assissted Therapy

Houston Bionics ExoRehab X brand/model device was used for improving the upper extremity in subacute stroke.

PROCEDURE

Conventional Rehabilitation

It is an upper extremity rehabilitation program prepared in line with individual needs.

Sponsors & Collaborators

  • Emresenocak

    lead OTHER

Principal Investigators

  • Aysel Yildiz Ozer, PhD · Marmara University

  • Adem Aktürk, PhD · Gelişim University

  • Elif Korkut, PhD · Bağcılar Education and Research Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-02
Primary Completion
2022-06-17
Completion
2022-08-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05559385 on ClinicalTrials.gov